The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China

The aim of the study is to evaluate the relationship between the adverse events and efficacy of sorafenib in patients with metastatic renal cell carcinoma (mRCC), with a purpose to guide the judgment of efficacy in sorafenib treatment. Eighty-three mRCC patients who received sorafenib therapy at nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu, Wang, Fuli, Wu, Guojun, Zhang, Longlong, Wang, Yangmin, Wang, Zhiping, Chen, Peng, Wang, Qing, Lu, Jingyi, Wang, Yujie, Li, Peijun, Wang, Jian, Lu, Xitao, Yuan, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008507/
https://www.ncbi.nlm.nih.gov/pubmed/26656362
http://dx.doi.org/10.1097/MD.0000000000002222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008507/
https://www.ncbi.nlm.nih.gov/pubmed/26656362
http://dx.doi.org/10.1097/MD.0000000000002222

Ejemplares similares